Pilot Evaluation of Gabapentin for Treating Hot Flashes
Authors:
- Charles L. LoprinziCLCharles L. Loprinzi
- Debra L. BartonDBDebra L. Barton
- Jeff A. SloanJSJeff A. Sloan
- Katherine M. ZahaskyKZKatherine M. Zahasky
- De Anne R. SmithDSDe Anne R. Smith
- Sandhya PruthiSPSandhya Pruthi
- Paul J. NovotnyPNPaul J. Novotny
- Edith A. PerezEPEdith A. Perez
- Bradley J. ChristensenBCBradley J. Christensen
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 77 (11) , 1159-1163
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Methodologic Lessons Learned From Hot Flash StudiesJournal of Clinical Oncology, 2001
- Management of hot flashes in breast-cancer survivorsThe Lancet Oncology, 2001
- Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialThe Lancet, 2000
- Estrogen Deficiency: In Search of Symptom Control and SexualityJNCI: Journal of the National Cancer Institute, 2000
- Managing Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled TrialJNCI: Journal of the National Cancer Institute, 2000
- Gabapentin’s effects on hot flashes and hypothermiaNeurology, 2000
- Tamoxifen-Induced Hot FlashesClinical Breast Cancer, 2000
- Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.Journal of Clinical Oncology, 1998
- A brief poms measure of distress for cancer patientsJournal of Chronic Diseases, 1987
- Measuring the quality of life of cancer patientsJournal of Chronic Diseases, 1981